taxifolin has been researched along with concanavalin a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Fujino, M; Hei, M; Kimura, S; Li, XK; Takahara, T; Tomita, A; Toyama, S; Yang, Z; Zhao, L; Zhao, M; Zhong, L; Zhu, P; Zhuang, J | 1 |
Chen, J; Mao, Q; Sun, X; Xia, T; Zhong, L | 1 |
2 other study(ies) available for taxifolin and concanavalin a
Article | Year |
---|---|
Dihydroquercetin (DHQ) ameliorated concanavalin A-induced mouse experimental fulminant hepatitis and enhanced HO-1 expression through MAPK/Nrf2 antioxidant pathway in RAW cells.
Topics: Animals; Antioxidants; Autoimmune Diseases; Cell Line; Concanavalin A; Extracellular Signal-Regulated MAP Kinases; Heme Oxygenase-1; Hepatitis; Humans; Immunity; Interferon-gamma; Macrophages; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Models, Animal; NF-E2-Related Factor 2; Quercetin; Signal Transduction; Tumor Necrosis Factor-alpha | 2015 |
Pretreatment with dihydroquercetin, a dietary flavonoid, protected against concanavalin A-induced immunological hepatic injury in mice and TNF-α/ActD-induced apoptosis in HepG2 cells.
Topics: Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Concanavalin A; Hep G2 Cells; Humans; Interleukin-10; Interleukin-2; Liver; Male; Mice; Mice, Inbred BALB C; Nitric Oxide Synthase Type II; Quercetin; Tumor Necrosis Factor-alpha | 2018 |